Delivery Order SPE2DB22D6029-SPE2DB24FLSXD

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Forteo 600 mcg/2.4 ml pen injections with a potential value of $1,756.81. The contract is a firm fixed price delivery order with a completion date of January 18, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $8,366.64, is for the delivery of Forteo 600 mcg/2.4 ml injectable pens. This is a firm fixed-price delivery order contract with a completion date of September 9, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,772.06 firm fixed-price delivery order is for the supply of 600 mcg/2.4 ml Forteo pen injections. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Forteo 600 mcg/2.4 ml pen injections in 2.4 ml doses. The $4,028.53 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which allows DLA to efficiently procure a wide range of pharmaceutical products and medical supplies for military treatment programs and...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of 4564531093 units of Forteo 600 mcg/2.4 ml pen injections. The $2,468.06 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,873.46, is for the delivery of Forteo 600 MCG/2.4 ML Pen Inj 2.4ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $64,690.92, is for the delivery of Forteo 600 MCG/2.4 ML Pen Injection 2.4ML, a medication used to treat osteoporosis. This is a firm fixed-price delivery order contract with a completion date of September 6, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,677.47 firm-fixed-price contract is for the delivery of Forteo 560 mcg/2.24 ml pen injections. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that allows AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml pen injector. The delivery order, valued at $10,494.33, is a firm-fixed-price contract with a completion date of September 23, 2024. AmerisourceBergen, through its Corporate Office division, will provide this critical medication to support military treatment facilities and other federal healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,355.87 Delivery Order (DO) contract is for the supply of Forteo 600 MCG/2.4 ML Pen Inj 2.4ML, a specialty medication. The award has a completion date of September 27, 2024 and is a Firm Fixed Price (FFP) contract type. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FLSXD
    Delivery Order

This federal contract award, valued at $1,772.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Forteo 600 MCG/2.4 ML Pen Inj 2.4ML, a prescription medication. This is a delivery order contract with a firm fixed price structure. The contract has an ultimate completion date of August 28, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceutical products and medical supplies to support various government healthcare programs, including for military treatment facilities and veterans' hospitals. This specific contract award does not have a set-aside designation.

Generated 11/26/24, 9:32 AM